# Bone Turnover in Type 2 Diabetes Patients

> **NCT00732121** · PHASE4 · UNKNOWN · sponsor: **University of Vermont** · enrollment: 20 (estimated)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** Sitagliptin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00732121
- **Lead sponsor:** University of Vermont
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-08
- **Primary completion:** 2010-06
- **Final completion:** 2010-08
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2010-06-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00732121

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00732121, "Bone Turnover in Type 2 Diabetes Patients". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00732121. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*